Literature DB >> 26721612

Role of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.

Lindsay B Conner1, Pedro Alvarez1, Oliver Bogen1, Jon D Levine2.   

Abstract

UNLABELLED: We hypothesized that changes in the expression of voltage-gated potassium channel (Kv) 4.3 contribute to the mechanical hyperalgesia induced by vibration injury, in a rodent model for hand-arm vibration syndrome in humans. Here we show that the exposure of the gastrocnemius muscle to vibration injury induces muscle hyperalgesia that is accompanied by a significant downregulation of Kv4.3 in affected sensory nerve fibers in dorsal root ganglia. We additionally show that the intrathecal administration of antisense oligonucleotides for Kv4.3 messenger RNA itself induces muscle hyperalgesia in the rat. Our results suggest that attenuation in the expression of Kv4.3 may contribute to neuropathic pain in people affected by hand-arm vibration syndrome. PERSPECTIVE: Our findings establish Kv4.3 as a potential molecular target for the treatment of hand-arm vibration syndrome.
Copyright © 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hand–arm vibration syndrome; isolectin B4 binding nociceptors; muscle hyperalgesia; neuropathic pain; voltage-gated potassium channels

Mesh:

Substances:

Year:  2015        PMID: 26721612      PMCID: PMC4818681          DOI: 10.1016/j.jpain.2015.12.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  57 in total

Review 1.  Vibration damage to the hand: clinical presentation, prognosis and length and severity of vibration required.

Authors:  J Fridén
Journal:  J Hand Surg Br       Date:  2001-10

2.  Downregulation of voltage-gated potassium channel alpha gene expression in dorsal root ganglia following chronic constriction injury of the rat sciatic nerve.

Authors:  Dong Sun Kim; Jeong Ock Choi; Hyo Deog Rim; Hee Jung Cho
Journal:  Brain Res Mol Brain Res       Date:  2002-09-30

3.  Kv7.2 regulates the function of peripheral sensory neurons.

Authors:  Chih H King; Eric Lancaster; Daniela Salomon; Elior Peles; Steven S Scherer
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

4.  Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positive.

Authors:  Oliver Bogen; Olaf Bender; Jana Löwe; Wolfgang Blenau; Beatrice Thevis; Wolfgang Schröder; Richard U Margolis; Jon D Levine; Ferdinand Hucho
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

5.  Peripheral neuropathic pain: signs, symptoms, mechanisms, and causes: are they linked?

Authors:  L A Colvin; P M Dougherty
Journal:  Br J Anaesth       Date:  2014-09-24       Impact factor: 9.166

Review 6.  Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms.

Authors:  Troels S Jensen; Nanna B Finnerup
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

7.  Distinct potassium channels on pain-sensing neurons.

Authors:  M N Rasband; E W Park; T W Vanderah; J Lai; F Porreca; J S Trimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

8.  Muscle hyperalgesia induced by peripheral P2X3 receptors is modulated by inflammatory mediators.

Authors:  J G Schiavuzzo; J M Teixeira; B Melo; D F da Silva dos Santos; C O Jorge; M C G Oliveira-Fusaro; C A Parada
Journal:  Neuroscience       Date:  2014-11-20       Impact factor: 3.590

9.  Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C.

Authors:  K O Aley; R O Messing; D Mochly-Rosen; J D Levine
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 10.  Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation.

Authors:  Guido Stoll; Sebastian Jander; Robert R Myers
Journal:  J Peripher Nerv Syst       Date:  2002-03       Impact factor: 3.494

View more
  8 in total

1.  Nociceptor Interleukin 33 Receptor/ST2 Signaling in Vibration-Induced Muscle Pain in the Rat.

Authors:  Pedro Alvarez; Oliver Bogen; Jon D Levine
Journal:  J Pain       Date:  2019-09-25       Impact factor: 5.820

2.  Kv4.3 Channel Dysfunction Contributes to Trigeminal Neuropathic Pain Manifested with Orofacial Cold Hypersensitivity in Rats.

Authors:  Hirosato Kanda; Jennifer Ling; Ya-Ting Chang; Ferhat Erol; Viacheslav Viatchenko-Karpinski; Akihiro Yamada; Koichi Noguchi; Jianguo G Gu
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

3.  Nociceptor interleukin 10 receptor 1 is critical for muscle analgesia induced by repeated bouts of eccentric exercise in the rat.

Authors:  Pedro Alvarez; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  Pain       Date:  2017-08       Impact factor: 7.926

4.  Effects of bradykinin on voltage-gated KV 4 channels in muscle dorsal root ganglion neurons of rats with experimental peripheral artery disease.

Authors:  Qin Li; Lu Qin; Jianhua Li
Journal:  J Physiol       Date:  2021-06-11       Impact factor: 6.228

5.  Interleukin 6 decreases nociceptor expression of the potassium channel KV1.4 in a rat model of hand-arm vibration syndrome.

Authors:  Pedro Alvarez; Oliver Bogen; Jon D Levine
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

Review 6.  A-Type KV Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction.

Authors:  Benjamin M Zemel; David M Ritter; Manuel Covarrubias; Tanziyah Muqeem
Journal:  Front Mol Neurosci       Date:  2018-08-06       Impact factor: 5.639

7.  IL-6 signaling pathway contributes to exercise pressor reflex in rats with femoral artery occlusion in association with Kv4 activity in muscle afferent nerves.

Authors:  Qin Li; Lu Qin; Jianhua Li
Journal:  Physiol Rep       Date:  2021-07

8.  Newly Discovered Action of HpTx3 from Venom of Heteropoda venatoria on Nav1.7 and Its Pharmacological Implications in Analgesia.

Authors:  Xinzhou Wu; Zhouquan Wang; Yu Chen; Dehong Xu; Peng Zhang; Xianchun Wang
Journal:  Toxins (Basel)       Date:  2019-11-20       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.